Jennifer Buell
Chief Executive Officer bij MINK THERAPEUTICS, INC.
Vermogen: 210 808 $ op 31-03-2024
Profiel
Jennifer S.
Buell currently works at MiNK Therapeutics, Inc., as President, Chief Executive Officer & Director from 2021, AgenTus Therapeutics Ltd., as Chief Executive Officer, AgenTus Therapeutics SA, as Chief Executive Officer, and Protagenic Therapeutics, Inc., as Independent Director from 2020.
Dr. Buell also formerly worked at Agenus, Inc., as President & Chief Operating Officer from 2019 to 2021.
Dr. Buell received her graduate degree in 2004 and doctorate degree in 2007 from Tufts University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
MINK THERAPEUTICS, INC.
0.67% | 16-01-2024 | 232 165 ( 0.67% ) | 210 806 $ | 31-03-2024 |
| 25-03-2024 | 1 ( 0.00% ) | 2 $ | 31-03-2024 |
Actieve functies van Jennifer Buell
| Bedrijven | Functie | Begin |
|---|---|---|
| PROTAGENIC THERAPEUTICS, INC. | Director/Board Member | 18-07-2020 |
| MINK THERAPEUTICS, INC. | Chief Executive Officer | 01-02-2021 |
| AgenTus Therapeutics SA | Chief Executive Officer | - |
| AgenTus Therapeutics Ltd. | Chief Executive Officer | - |
Eerdere bekende functies van Jennifer Buell
| Bedrijven | Functie | Einde |
|---|---|---|
| AGENUS INC. | President | 31-12-2021 |
Opleiding van Jennifer Buell
| Tufts University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| AGENUS INC. | Health Technology |
| PROTAGENIC THERAPEUTICS, INC. | Health Technology |
| MINK THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
| AgenTus Therapeutics Ltd. | |
| AgenTus Therapeutics SA |
